Study Group: Users of Reloxin: Dermatologists(?)
Council Members in this Study Group: 100
Request a survey with this Study Group
Leading Experts in this Study Group
Director of Clinical Research - Dermatology
ST LUKE'S-ROOSEVELT HOSPITAL CENTER
Jeffrey Weinberg, MD, is the Director of the Clinical Research Center in the Department of Dermatology at St. Luke's-Roosevelt Hospital Center and Beth Israel Medical Center in New York. He is also an Assistant Clinical Professor in the Dermatology Department at Columbia University College of Physicians...
Owner
Kenneth Edelson, MD
Kenneth Edelson, MD, FAACS, is a Dermatologist in private practice in New York, since July 1980. He specializes in skin cancer as well as cosmetic dermatology, including lasers and IPL's for facial rejuvenation and skin tightening, vascular lesions, pigmentation, and cellulite. Dr. Edelson uses lasers...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Dermatologists (US) | 588 |
| Physicians who Treat Acne (US) | 286 |
| Cosmetic Dermatologists | 333 |
| Users of Dermal Fillers (US) | 132 |
| Cosmetic Dermatologists (US) | 262 |
| Hair Restoration Dermatologists (US) | 266 |
| Cosmetic Dermatologists in Private Practice (US) | 174 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
fillers are important in cosmetic practice but caution must be observed till insurer is ready to compensate for any loss done.
Tacrolimus is used either alone or with topical steroids in acute stages while tacrolimus alone is preferred for maintenance so as to reduce the side effects of steroids. Relapses are a rule rather than exception in atopic dermatitis. Use of moisturizing cleansers, emollients and avoidance of irritants...
- Dark circles underneath the eyes give the unappealing impression of exhaustion. Many factors, both hereditary and environmental, can produce or exacerbate this condition. - Despite efforts to address this unmet need, the over-the-counter cosmetic industry has not been able to address consumer's...
On Tuesday, the FDA's Dermatologic and Ophthalmic Drug Advisory Panel voted unanimously to approve the use of the injectable drug for the treatment of plaque psoriasis, a severe skin disease. As the FDA usually follows the recommendations of its advisory panels when reviewing new drugs for approval,...
(Directly pulled from the article.) Patients were randomly assigned to receive 2 doses, 45 or 90 mg, of subcutaneous ustekinumab, given 4 weeks apart and followed by treatments every 12 weeks. Patients randomly assigned to receive 45 mg had a sustained PASI 75 (indicating an improvement in psoriatic...
GLG InstituteSM Seminars with this Study Group's Leading Experts(?)
Recent Seminars
Most Common Company Types:
- Office Based Private Practice or Clinic
- Academic Medical Center/Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Owner
- Physician - Director
- Director
- Physician - Division Head
- President
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

